Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where José De Andrés is active.

Publication


Featured researches published by José De Andrés.


Pain | 2008

Postoperative Analgesic THerapy Observational Survey (PATHOS): a practice pattern study in 7 central/southern European countries.

Dan Benhamou; Marco Berti; Gerhard Brodner; José De Andrés; Gaetano Draisci; Mariano Moreno-Azcoita; Edmund Neugebauer; Wolfgang Schwenk; L. Torres; Eric Viel

&NA; Surveys evaluating pain in hospitals keep on showing that postoperative pain (POP) remains undertreated. At the time when guidelines are edited and organisational changes are implemented, more recent data are necessary to check the impact of these measures on daily practice and needs for improvement. This prospective, cross‐sectional, observational, multi‐centre practice survey was performed in 2004–2005 in 7 European countries. It was conducted in surgical wards of a randomised sample of hospitals. Data on POP management practices following surgery in adult in‐patients were collected anonymously via a standardised multiple choice questionnaire. Among 1558 questionnaires received from 746 European hospitals, 59% were provided by anaesthetists and 41% by surgeons. There are no regular on‐site staff training programmes on POP management in the institution for 34% of the respondents, patients are systematically provided with POP information before surgery for 48% of respondents; balanced analgesia following major surgery and regular administration of analgesics are largely used; 25% of respondents have specific written POP management protocols for all patients in their ward; 34% of respondents say that pain is not assessed and 44% say that pain scores are documented in the patient’s chart. This largest ever performed survey confirms the extensive body of evidence that current POP management remains suboptimal and identifies needs for improvement on European surgical wards. However, the wide use of balanced analgesia and the regular administration of analgesics are indicators of ongoing change.


Neuromodulation | 2012

Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel: INTRATHECAL THERAPY CONSENSUS

Timothy R. Deer; Joshua Prager; Robert M. Levy; James P. Rathmell; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark T. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh

Introduction:  The use of intrathecal (IT) infusion of analgesic medications to treat patients with chronic refractory pain has increased since its inception in the 1980s, and the need for clinical research in IT therapy is ongoing. The Polyanalgesic Consensus Conference (PACC) panel of experts convened in 2000, 2003, and 2007 to make recommendations on the rational use of IT analgesics based on preclinical and clinical literature and clinical experiences.


Anesthesia & Analgesia | 2002

The origin of the spinal subdural space: ultrastructure findings.

Miguel Angel Reina; Oscar de Leon Casasola; Andrés López; José De Andrés; Miguel Mora; Agustín Fernández

Previous studies of samples from cranial meninges have created doubts about the existence of a virtual subdural space. We examined the ultrastructure of spinal meninges from three human cadavers immediately after death to see whether there is a virtual subdural space at this level. The arachnoid mater had two portions: a compact laminar portion covering the dural sac internal surface and a trabecular portion extending like a spider web around the pia mater. There was a cellular interface between the laminar arachnoid and the internal layer of the dura that we called the dura-arachnoid interface. There was no subdural space in those specimens where the dura mater was macroscopically in continuity with the arachnoid trabecules. In the specimens where the dura mater was separated from the arachnoid, we found fissures in between the neurothelial cells that extended throughout the interface. We hypothesize that the subdural space would have its origin within the dura-arachnoid interface when the neurothelial cells break up, creating in this way a real subdural space.


Regional Anesthesia and Pain Medicine | 2001

peripheral Nerve Stimulation in the Practice of Brachial Plexus Anesthesia : a Review

José De Andrés; Xavier Sala-Blanch

Success of plexus nerve block is dependent on the correct positioning of the local anesthetic solution near the desired nerves.1,2 Throughout the history of regional anesthesia, elicitation of paresthesia has been a classical method to locate nerves, while mechanical aids, including radioscopy3 and peripheral nerve stimulation (PNS),4,5 have been promoted to facilitate close approximation of needle and nerve, theoretically increasing the corresponding success rate.2 Experience with electrical stimulation for locating nerves suggests it is beneficial in teaching regional anesthetic techniques to residents in training, performing difficult nerve blocks, or using novel approaches and smaller doses of local anesthetic.1,2,6 Further, nerve stimulation can be used effectively for less cooperative patients and in anesthetized patients,7 though the risk of neural injury remains present.8 Electrical stimulation facilitates the localization of nerves, and its use does not eliminate the need for basic technical knowledge: in effect, knowledge of the anatomy of the area to be blocked, the muscle innervation scheme, applied neurophysiology, and the pharmacology of the local anesthetic used. Consideration of these factors is important to evaluate the conflicting results in the PNS literature—results that in some cases are reportedly inferior to those of more classical methods, having only 2 series effectively confirm that nerve stimulation affords an increased success rate with plexus block.9,10 For these reasons, the objective of our article is to review the applied neurophysiology and the principal features of the use of PNS in regional anesthesia.


Neuromodulation | 2012

Polyanalgesic Consensus Conference--2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain.

Timothy R. Deer; Robert M. Levy; Joshua Prager; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh; Nagy Mekhail

Introduction:  Targeted intrathecal drug infusion to treat moderate to severe chronic pain has become a standard part of treatment algorithms when more conservative options fail. This therapy is well established in the literature, has shown efficacy, and is an important tool for the treatment of both cancer and noncancer pain; however, it has become clear in recent years that intrathecal drug delivery is associated with risks for serious morbidity and mortality.


Neuromodulation | 2012

Polyanalgesic Consensus Conference--2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel.

Timothy R. Deer; Joshua Prager; Robert M. Levy; Allen W. Burton; Eric Buchser; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Phillip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; B. Todd Sitzman; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh; Nagy Mekhail

Introduction:  Trialing for intrathecal pump placement is an essential part of the decision‐making process in placing a permanent device. In both the United States and the international community, the proper method for trialing is ill defined.


Neuromodulation | 2012

Polyanalgesic Consensus Conference—2012: Consensus on Diagnosis, Detection, and Treatment of Catheter‐Tip Granulomas (Inflammatory Masses)

Timothy R. Deer; Joshua Prager; Robert M. Levy; James P. Rathmell; Eric Buchser; Allen W. Burton; David Caraway; Michael Cousins; José De Andrés; Sudhir Diwan; Michael A. Erdek; Eric Grigsby; Marc A. Huntoon; Marilyn S. Jacobs; Philip Kim; Krishna Kumar; Michael Leong; Liong Liem; Gladstone McDowell; Sunil Panchal; Richard Rauck; Michael Saulino; B. Todd Sitzman; Peter S. Staats; Michael Stanton-Hicks; Lisa Stearns; Mark S. Wallace; K. Dean Willis; William W. Witt; Tony L. Yaksh

Introduction:  Continuous intrathecal infusion of drugs to treat chronic pain and spasticity has become a standard part of the algorithm of care. The use of opioids has been associated with noninfectious inflammatory masses at the tip of the intrathecal catheter, which can result in neurologic complications.


Neuromodulation | 2017

The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines

Timothy R. Deer; Jason E. Pope; Salim M. Hayek; Anjum Bux; Eric Buchser; Sam Eldabe; José De Andrés; Michael A. Erdek; Dennis Patin; Jay S. Grider; Daniel M. Doleys; Marilyn S. Jacobs; Tony L. Yaksh; Lawrence Poree; Mark S. Wallace; Joshua Prager; Richard Rauck; Oscar DeLeon; Sudhir Diwan; Steven M. Falowski; Helena M. Gazelka; Philip Kim; Michael Leong; Robert M. Levy; Gladstone McDowell; Porter McRoberts; Ramana K. Naidu; Narouze S; Christophe Perruchoud; Steven M. Rosen

Pain treatment is best performed when a patient‐centric, safety‐based philosophy is used to determine an algorithmic process to guide care. Since 2007, the International Neuromodulation Society has organized a group of experts to evaluate evidence and create a Polyanalgesic Consensus Conference (PACC) to guide practice.


Pain Practice | 2008

Peripheral Neurostimulation in Supraorbital Neuralgia Refractory to Conventional Therapy

Juan M. Asensio‐Samper; V. Villanueva; Alfonso V. Pérez; María D. López; Vicente Monsalve; S. Moliner; José De Andrés

▪ Abstract:  Supraorbital neuralgia has been identified as an infrequent cause of headache that may prove very difficult to control pharmacologically. Peripheral nerve stimulation using electrodes to stimulate the nerve segmentally responsible for the zone of pain may constitute a management alternative in such cases. We present the case of a patient with headache because of posttraumatic supraorbital neuralgia, refractory to medical treatment, with good analgesic control after peripheral nerve stimulation.


Pain Practice | 2006

Neural modulation by stimulation.

José De Andrés; Jean-Pierre Van Buyten

Abstract:  Spinal cord stimulation (SCS) for the treatment of neuropathic pain is supported by good‐quality randomized controlled trials, prospective and retrospective case studies, and observational case series that confirm its efficacy and safety. SCS has been successfully used in various refractory neuropathic pain conditions, including failed back surgery syndrome (FBSS), neuropathic back and leg pain, and complex regional pain syndrome (CRPS) types I and II. According to the Harbour and Miller Scale (2001), the evidence for SCS in FBSS has been classified as grade B, while that for CRPS type I has been classified as grade A. Clinical evidence has shown that compared to conventional pain therapy, more than two‐thirds of carefully selected patients treated with SCS achieved sustained pain relief of 50% or more, with minimal side effects. Many patients were able to reduce their analgesic consumption. Quality of life improved and the majority of patients were happy with their treatment; in some cases, patients were able to return to work. Trial stimulation, which is relatively inexpensive and completely reversible, provides predictive value for long‐term efficacy and increases the cost‐effectiveness of permanent implantation. Studies consistently report that over time, SCS is potentially cost saving to the healthcare system. At present, SCS is considered a “last resort” in the treatment of refractory neuropathic pain, yet evidence suggests that early intervention with SCS results in greater efficacy and, in the case of FBSS, should be considered before re‐operation.

Collaboration


Dive into the José De Andrés's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrés López

CEU San Pablo University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joshua Prager

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge